Medical Confidentiality, Data Protection and Freedom of Information Sample Clauses

Medical Confidentiality, Data Protection and Freedom of Information. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Trial Subjects involved in the Clinical Trial. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor or CRO by the Trust save where this is required to satisfy the requirements of the Protocol or for the purpose of monitoring or adverse event reporting, or in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial. Neither the Sponsor nor CRO shall disclose the identity of Clinical Trial Subjects to third parties without prior written consent of the Clinical Trial Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Confidentiality Code of Practice (November 2003), unless in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial.
Sample 1Sample 2Sample 3See All (16)
AutoNDA by SimpleDocs
Medical Confidentiality, Data Protection and Freedom of Information. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Investigation Subjects involved in the Clinical Investigation. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the Board save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation. The Sponsor shall not disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Scotland Code of Practice on Protecting Patient Confidentiality (August 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.
Sample 1Sample 2Sample 3See All (9)
Medical Confidentiality, Data Protection and Freedom of Information. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Investigation Subjects involved in the Clinical Investigation. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor or CRO by the Trust save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation. Neither the Sponsor nor CRO shall disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Confidentiality Code of Practice (November 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.
Sample 1Sample 2Sample 3See All (5)
Medical Confidentiality, Data Protection and Freedom of Information. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Investigation Subjects involved in the Clinical Investigation. Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the NHS Body save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation. The Sponsor shall not disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the “Confidentiality: Code of Practice for Health and Social Care in Wales (August 2005)”, unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.
Sample 1
Medical Confidentiality, Data Protection and Freedom of Information. The Parties agree to adhere to the principles of medical confidentiality in relation to Clinical Trial Subjects involved in the Clinical Trial. Personal data (as defined in the DPA) shall not be disclosed to the Sponsor by the Institution or the Investigator save where this is required to satisfy the requirements of the Protocol or for the purpose of monitoring or adverse event reporting, or in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial. The Sponsor shall not disclose the identity of Clinical Trial Subjects to third parties without prior written consent of the Clinical Trial Subject, unless in relation to a claim or proceeding brought by the Clinical Trial Subject in connection with the Clinical Trial.
Sample 1

Related to Medical Confidentiality, Data Protection and Freedom of Information

  • DATA PROTECTION AND FREEDOM OF INFORMATION 7.1. Each party will:-

  • Data Protection and Confidentiality 3.1.We obtain, use, process and disclose personal data about you and data subjects (as defined in the DPA) in order that we may provide services under the Agreement and for other related purposes including updating and enhancing client records, analysis for management purposes and statutory returns, crime prevention and legal and regulatory compliance.

  • Confidentiality and Data Protection 12.1. The parties undertake to keep technical and commercial information of each other secret, except for publicly available information which has become known to them while executing the present agreement, and not transfer it to third parties without a written consent from the other party or its legal representatives.

  • Confidentiality Data Protection The terms and conditions of this Agreement are confidential and may not be disclosed to or discussed with anyone except as permitted. Confidential information may include: any trade/business secret, technical knowledge or know-how, financial information, plans, customer/client lists, your customer information or data, your customers’ accounting or financial information, your customers’ tax information, your customers’ miscellaneous information, supplier information, pricing policies, fee structure, standard operating procedures, protocols, marketing data and/or promotional techniques, product data, purchase information, sales policies, employee lists, policies, computer records, computer access codes, plans and programs, any formula pattern or compilation of information, used during this Agreement, or any of its/ their clients. Confidentiality will exist regardless of whether such information is received by you under a validly executed confidentiality Agreement or not, or which is disclosed (whether in writing, delivery of items/ reports, manuals, verbally, visual representation, inspection of tangible objects, on office or site visits, or by any other means and whether directly or indirectly) whether before or after the date of this Agreement. Confidential Information may include “Proprietary information” as defined from now on. Each party shall honor the confidentiality and data protection of the other party’s “Confidential Information” and shall not disclose such information to any third party without the prior written consent of the confiding party. Neither party shall disclose any of the terms of this Agreement to assigned remote staff or any of other employees or affiliates, except the appointed Account Manager and person signing this Agreement on our behalf. To protect the Confidential Information, both the parties now agree and undertake to keep secret and treat as confidential all Confidential Information described above. Neither party shall use any Confidential Information at any time, either during this Agreement or after the termination of the Agreement, for any purpose other than in the ordinary course of business and furtherance of the confiding party’s interest. We may not be permitted to use your name as our client in any marketing literature, brochures, or for any private reference unless you permit it.

  • Confidentiality and Use of Information a) Contractor shall hold in trust for the District, and shall not disclose to any person, any confidential information. Confidential information is information which is related to the District’s research, development, trade secrets and business affairs; but does not include information which is generally known or easily ascertainable by nonparties through available public documentation.

  • Confidentiality of Information 8.1. By accessing this EHSAN AUCTIONEERS SDN. BHD. website, the E-Bidders acknowledge and agree that EHSAN AUCTIONEERS SDN. BHD. website may collect, retain, or disclose the E-Bidder’s information or any information by the e-bidders for the effectiveness of services, and the collected, retained or disclosed information shall comply with Personal Data Protection Act 2010 and any regulations, laws or rules applicable from time to time.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!